“Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment”, Braz. J. Radiat. Sci., vol. 10, nº 4, p. 1–16, dez. 2022, doi: 10.15392/2319-0612.2022.2047.